Literature DB >> 731800

Adrenal cortical carcinoma.

M Sullivan, M Boileau, C V Hodges.   

Abstract

A review of 28 cases of adrenal cortical carcinoma provides some insights into the natural history of this disease and suggests modifications in current techniques of diagnosis and management. Our patients ranged in age from 1 to 69 years but it is notable that all of our male patients were more than 39 years old. In addition the men tended to have high stage tumors that were nonfunctional. Female patients, on the other hand, were more evenly distributed in terms of stage, function and age at diagnosis. Staging was extremely important and is discussed in some detail. A dismayingly large number of patients were found to have stage 3 or 4 tumor at initial diagnosis, suggesting that aggressive and rapid evaluation and a high index of suspicion are important to optimize survival. Function is helpful but non-function is common and should not dissuade one from the diagnosis. Excretory urography with tomography followed by angiography frequently will provide the diagnosis. Endocrinologic evaluation should be done with alacrity. Survival with high stages of disease is poor and lengthy evaluation should not be allowed to delay prompt and, hopefully, curative surgery. Surgical resection is the key to cure; chemotherapy and radiotherapy provided relatively poor results in our hands although mitotane has shown a 34 to 54 per cent response rate.

Entities:  

Mesh:

Year:  1978        PMID: 731800     DOI: 10.1016/s0022-5347(17)57317-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  Current perspective in the diagnosis and treatment of adrenocortical carcinoma.

Authors:  D E Schteingart
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  A diagnostic approach to adrenal cortical lesions.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

3.  Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells.

Authors:  B Mariniello; I Finco; P Sartorato; A Patalano; M Iacobone; V Guzzardo; A Fassina; F Mantero
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

4.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

5.  Andrenocortical carcinomas: twelve-year prospective experience.

Authors:  Libuse Tauchmanovà; Annamaria Colao; Luigi Antonio Marzano; Lucianna Sparano; Luigi Camera; Annalisa Rossi; Giovanna Palmieri; Ettore Marzano; Marco Salvatore; Guido Pettinato; Gaetano Lombardi; Riccardo Rossi
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

6.  The incidentally discovered adrenal mass.

Authors:  P M Copeland
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

Review 7.  Cytotoxic treatment of adrenocortical carcinoma.

Authors:  H Ahlman; A Khorram-Manesh; S Jansson; B Wängberg; O Nilsson; C E Jacobsson; S Lindstedt
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

Review 8.  Adrenal cortical carcinoma.

Authors:  A P Dackiw; J E Lee; R F Gagel; D B Evans
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

Review 9.  Nonfunctional adrenal cortical carcinoma. Report of a case and review of the literature.

Authors:  E D Fokaefs; M D Melekos; M P Melachrinou; I E Zarakovitis; G A Barbalias
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

10.  Nonfunctioning adrenocortical carcinoma in a young girl.

Authors:  H Kishikawa; T Mizuno; I Takagi; Y Yamakawa; T Shimozato; K Honda; M Tatematsu
Journal:  Jpn J Surg       Date:  1985-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.